Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
68,652,138
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
1,068,443
-
Shares change
-
+116,143
-
Total reported value, excl. options
-
$5,606,000
-
Value change
-
+$363,613
-
Put/Call ratio
-
467%
-
Number of buys
-
18
-
Number of sells
-
7
-
Price
-
$5.27
Institutional Holders of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) as of Q2 2021
As of 30 Jun 2021 Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) had 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,068,443 shares of stock of the company.
Largest 10 holders included MARSHALL WACE, LLP, Ikarian Capital, LLC, NORRIS PERNE & FRENCH LLP/MI, SUSQUEHANNA INTERNATIONAL GROUP, LLP, STATE STREET CORP, GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., and COMERICA BANK.
This table shows 29 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.